In-Patient Services
Flourish Research has the facilities, staff experience, and equipment to perform a variety of Early Phase Studies, from First-in-Human to early proof of concept.
Built For Efficiency & Excellence
Our state-of-the-art facilities and dedicated teams are supported by centralized services that streamline every milestone, from study start to recruitment to database close.
Budgets & Contracts
Regulatory
SOPs
Training
QA/QC
Capabilities & Experiences
Studies
Patients
Staff Experience
Chief Medical Director
Dr. Denham Has Overseen More Than 100 Phase 1 Studies.
Chief Medical Director
Dr. Fakih Has Overseen 20 Phase 1 Studies.
Investigator
Dr. Hedges Has Conducted 20 Phase 1 Studies.
Investigator
Dr. Rosenthal Has Overseen 4 Phase 1 Studies.
Director Early Phase Services
Dr. Corral Has Conducted More Than 20 Phase 1 Studies.
Senior Director, Lab
Dr. Schmid Has More Than 35 Years Of Experience In Drug Discovery And Development.
Complex Inpatient Studies
Case Studies:
- Challenge: a complex schedule of 6 inpatient days, followed by 8 consecutive days of outpatient visits, with a 56-day washout, and then another 6-days inpatient/8-days outpatient series, with multiple PK and safety timepoints.
Success: Flourish randomized 33 participants in one month with 88% retention. - Challenge: a drug involving considerable potential side effects.
Success: Flourish randomized 72 participants with an 85% completion rate by preparing participants for potential side effects during informed consent and developing strong patient relationships
Top Enrollers:
- Flourish is consistently recognized as a top enroller, in healthy and special population studies, including rescue situations
- Robust prescreening program and special population databases
Early Phase Facilities & Equipment
- 57 inpatient beds
- Dedicated, secure overnight facilities
- Temperature data logging & phone alert system
- Synchronous Atomic Clocks
- Backup generators
- Dietician-planned meals
- IV infusion dosing/monitoring
- eDocs, eRegulatory for 24/7 access of data
- eSource
- Accommodations for sponsor/CROs for onsite observation of dosing/procedures
- Limited-access, temperature-controlled drug storage
- Pharmacy hood
- Ambient and refrigerated centrifuges
- Drug & specimen refrigerators
- -80°C and -20°C freezers
- ECG, with onsite interpretations
- EEG Procedures
- Spirometry
- Accredited sleep labs
- YSI machines (Biochemistry Analyzer)
- Crash Carts
PBMC Onsite Processing
Flourish Research offers in-house PBMC (Peripheral Blood Mononuclear Cell) services to meet client needs for the evaluation of cellular immune function within the clinical trial setting.
- Onsite processing eliminates the need for sample transport
- Network-wide SOPs and quality control
- Four labs supporting 8 sites across the U.S.
- Deliverable: high-yield, high-viability cryopreserved (PBMC) cells
- Oversight by PhD PBMC thought leader
Best-in-class facilities and processes:
- Temperature-controlled labs
- Isolation using Ficoll/CPT and/or other isolation techniques
- Class II A2 biosafety cabinets
- Fluorescent staining & image analysis
- Two-step cryopreservation process
- Long-term storage in vapor phase of liquid nitrogen at -135°C
Flourish Research News
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.